Lindsay Rocco | Investor Relations, Co-Founder and Managing Partner at ‎Elixir Health Public Relations |
Matthew Pauls | Chief Executive Officer, Director, President |
Fred Cohen | Chief Medical Officer |
Brian Davis | Chief Financial Officer. |
Annabel Samimy | Stifel |
Hartaj Singh | Oppenheimer & Co. |
Liisa Bayko | JMP Securities |
Elemer Piros | Cantor Fitzgerald |
Good day ladies and gentlemen and welcome to the Q1 2018 Strongbridge Biopharma plc earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be follow at that time. [Operator Instructions].
As a reminder, this conference call is being recorded.